Riskpilot← Back to searchSign inGet full accessNUCLEO AS
ASActiveOrg 924783613Blaklihøgda 7E, 7036 TrondheimWholesale of other food · NACE 4638Est. 20202 employees
Revenue 2024
NOK 946K
+30% vs 2023
EBITDA margin
7.4%
+151% vs 2023
Equity ratio
4.4%
Financial strength
Net profit 2024
NOK 60K
+139% vs 2023
| Revenue | NOK 946K | +30% |
| EBITDA | NOK 70K | +151% |
| Net profit | NOK 60K | +139% |
| Total assets | NOK 431K | +95% |
| Equity | NOK 19K | +146% |
| Employees | 2 | — |
Legal name
NUCLEO AS
Org number
924783613
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
24. mars 2020
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Kjøp, salg og distribusjon av næringsmidler og helseprodukter. Kostveiledning og oppfølging, personlig treningsveiledning, foredragsvirksomhet og erfaringskonsulentarbeid, samt produksjon og utgivelse av musikk- og lydopptak og underholdning, og annet som naturlig faller sammen med dette.
Address
Blaklihøgda 7E, 7036 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 251 | 1 130 | 984 | 727 | 946 |
| Staff expenses | −128 | −692 | −561 | −480 | −506 |
| EBITDA | 55 | 93 | −34 | −138 | 70 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 55 | 93 | −34 | −138 | 70 |
| Net financials | 0 | −1 | −2 | −7 | −10 |
| Profit before tax | 55 | 92 | −36 | −145 | 60 |
| Tax | 11 | 21 | −7 | 7 | −0 |
| Net profit | 45 | 71 | −28 | −153 | 60 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 184 | 362 | 297 | 220 | 431 |
| Equity | 69 | 140 | 112 | −41 | 19 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 115 | 221 | 185 | 261 | 412 |
| Total debt | 115 | 221 | 185 | 261 | 412 |
EBITDA margin
7.4%
This company
15.8%
Market median
-53% vs market
20202024
Equity ratio
4.4%
This company
38.2%
Market median
-88% vs market
20202024
Return on equity
315.7%
This company
18.4%
Market median
+1616% vs market
20202024
Net profit margin
6.3%
This company
8.1%
Market median
-22% vs market
20202024
Asset turnover
2.20×
This company
1.12×
Market median
+96% vs market
20202024
Debt / equity
21.79×
This company
0.62×
Market median
-3415% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NUCLEO AS 
PROFF RØR OG BYGGBoard members of NUCLEO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kent Aune | Chairman | 0 companies |
| Stine Elise Trøen Aune | Board of Directors | 0 companies |